What Is CJC-1295?
A modified GHRH analog that stimulates the pituitary to produce growth hormone — with significantly longer action than natural GHRH or Sermorelin.
CJC-1295 is a synthetic analog of Growth Hormone Releasing Hormone (GHRH) — the hypothalamic signal that triggers the pituitary gland to release growth hormone. It is based on the same first 29 amino acids of GHRH as Sermorelin, but with four key amino acid substitutions that dramatically increase its stability and half-life compared to both natural GHRH and Sermorelin.
CJC-1295 comes in two distinct variants that have meaningfully different pharmacokinetic profiles: CJC-1295 without DAC (also called Modified GRF 1-29 or Mod GRF 1-29) produces a pulsatile GH release pattern that mimics natural physiology. CJC-1295 with DAC (Drug Affinity Complex) binds to albumin in the bloodstream, extending its half-life from ~30 minutes to approximately 8 days — producing a prolonged "GH bleed" rather than a pulsatile pulse.
This variant distinction is one of the most important and most misunderstood aspects of CJC-1295 use. The choice between DAC and no-DAC has significant implications for how the compound affects GH physiology — and most practitioners in the longevity space now prefer the without DAC version for its more physiological pulsatile GH release pattern.
Both CJC-1295 (without DAC) and Sermorelin are GHRH analogs that stimulate pulsatile GH release. The key difference is half-life: Sermorelin has a half-life of ~10–20 minutes; CJC-1295 without DAC has a half-life of ~30 minutes. This longer window gives CJC-1295 a larger GH pulse amplitude per injection. Both preserve the natural feedback loop that prevents excess — making either a safer choice than exogenous HGH. CJC-1295 with DAC, by contrast, produces a sustained GH elevation for days — a fundamentally different and less physiological pattern.
How Does CJC-1295 Work?
Four mechanisms explain CJC-1295's GH-stimulating and downstream anti-aging effects.
CJC-1295 binds to GHRH receptors on pituitary somatotroph cells — triggering the release of stored growth hormone. This is the same receptor that natural GHRH activates, but CJC-1295's modified amino acid sequence makes it resistant to the dipeptidyl peptidase-IV (DPP-IV) enzyme that rapidly degrades natural GHRH. The result is a longer receptor activation window and larger GH pulse.
Growth hormone released by CJC-1295 stimulates the liver to produce IGF-1 — the primary downstream mediator of GH's anabolic and regenerative effects. Elevated IGF-1 drives muscle protein synthesis, fat metabolism, bone density maintenance, and tissue repair. Tracking IGF-1 levels is the standard way to assess CJC-1295 protocol efficacy.
The largest natural GH pulse occurs during slow-wave sleep. CJC-1295 administered before bed amplifies this nocturnal pulse — improving deep sleep quality and duration while maximizing the anabolic and regenerative benefits of nighttime GH secretion. This creates a positive feedback loop: better GH pulse → better sleep → better GH pulse the following night.
Like Sermorelin, CJC-1295 (without DAC) works within the natural GH feedback system. When GH and IGF-1 reach appropriate levels, somatostatin is released to inhibit further GH secretion — preventing excess. This self-regulating mechanism is absent with exogenous HGH and is one of the primary safety advantages of GHRH analogs over synthetic HGH.
CJC-1295 With DAC vs Without DAC
The most important distinction in CJC-1295 — two very different pharmacological profiles under one name.
| Feature | CJC-1295 Without DAC | CJC-1295 With DAC |
|---|---|---|
| Also known as | Modified GRF 1-29, Mod GRF 1-29 | CJC-1295 DAC |
| Half-life | ~30 minutes Physiological | ~8 days |
| GH release pattern | Pulsatile — mimics natural physiology Preferred | Sustained "GH bleed" |
| Injection frequency | Daily or 3x weekly | Once weekly Convenient |
| Feedback loop | ✅ Preserved — self-regulating | ⚠️ Partially bypassed |
| Preferred by | Most longevity practitioners Recommended | Some bodybuilding contexts |
| Best stacked with | Ipamorelin — daily before bed | Less commonly stacked |
| Practitioner consensus | First choice for anti-aging protocols | Less preferred — less physiological |
For anti-aging and longevity applications — CJC-1295 without DAC is the preferred choice. Its pulsatile GH release pattern mirrors natural physiology, preserves the feedback loop that prevents excess, and stacks synergistically with Ipamorelin for amplified pulsatile release. CJC-1295 with DAC's week-long sustained GH elevation is considered less physiological and is less commonly recommended by longevity-focused practitioners.
What Is CJC-1295 Used For?
The downstream effects of restored GH pulsatility touch virtually every system affected by aging.
- Body Composition — Muscle & FatThe most sought-after application. Restored GH and IGF-1 support lean muscle maintenance and growth while enhancing fat metabolism — particularly visceral fat reduction. Body composition improvements become measurable over 3–6 months of consistent protocol adherence combined with appropriate training and nutrition.
- Deep Sleep QualityOften the earliest and most noticeable benefit — users consistently report significantly improved sleep depth within the first 2–4 weeks. The nocturnal GH pulse amplification produces measurable improvements in slow-wave sleep architecture that cascade into energy, recovery, and cognitive function.
- Recovery & Tissue RepairGH and IGF-1 are critical drivers of tissue repair — accelerating recovery from exercise, injury, and surgical procedures. CJC-1295 is particularly popular among athletes and active adults for its recovery-enhancing effects alongside body composition benefits.
- Cognitive Function & EnergyGH receptors are present throughout the brain. Restored GH pulsatility supports neuronal health, mental clarity, and the energy levels that decline with age-related GH reduction. Many users report improved cognitive stamina and motivation alongside physical benefits.
- Skin & CollagenGH and IGF-1 stimulate collagen synthesis and skin cell turnover — supporting skin thickness, elasticity, and the reduction of fine lines associated with collagen loss. Particularly meaningful when combined with GHK-Cu for comprehensive skin anti-aging.
- Bone DensityGH and IGF-1 are critical regulators of bone metabolism and density — a key longevity consideration for adults over 45 facing age-related bone density decline. Particularly relevant for post-menopausal women where estrogen-dependent bone protection has declined.
How to Use CJC-1295
Almost always used in combination with Ipamorelin — the GHRH + GHRP synergy produces significantly larger GH pulses than either alone.
CJC-1295 must be administered in a fasted state — food intake, particularly carbohydrates and fats, elevates insulin which directly suppresses GH release. Administer at least 2 hours after your last meal and at least 30 minutes before eating. The nightly before-bed window is optimal because it aligns with the natural nocturnal GH pulse and the overnight fasted state. Never administer with or immediately after meals.
CJC-1295 vs Sermorelin vs Ipamorelin
Understanding the GH secretagogue landscape — GHRH analogs vs GHRPs and how they differ.
| Feature | CJC-1295 (no DAC) | Sermorelin | Ipamorelin |
|---|---|---|---|
| Type | GHRH analog | GHRH analog | GHRP (ghrelin mimetic) |
| Half-life | ~30 min Longer | ~10–20 min | ~2 hours |
| GH pulse size | Large Strongest GHRH | Moderate | Moderate alone — synergistic with GHRH |
| FDA history | None | ✅ FDA approved (pediatric) Best history | None |
| Cortisol/prolactin | Not affected | Not affected | Minimal — cleanest GHRP Safest |
| Best stacked with | Ipamorelin Classic combo | Ipamorelin | CJC-1295 or Sermorelin |
| Best for | Larger GH pulse, body comp | Conservative, FDA history | Clean GH pulse, minimal sides |
CJC-1295 in a Longevity Stack
CJC-1295 anchors the GH optimization layer — stacking naturally with compounds that amplify or complement its effects.
- +CJC-1295 + Ipamorelin — The definitive GH secretagogue combination. CJC-1295 is a GHRH analog — it signals the pituitary to prepare and release GH. Ipamorelin is a GHRP (ghrelin receptor agonist) — it amplifies the GH pulse through a completely different receptor pathway. Together they produce synergistically larger GH pulses than either alone — with Ipamorelin's clean profile (minimal cortisol, minimal prolactin) making it the ideal GHRP partner. The most widely used GH optimization combination in functional medicine.
- +CJC-1295 + Epithalon — Epithalon restores pineal-hypothalamic-pituitary axis coordination — the upstream regulatory system that coordinates the nocturnal GH pulse. CJC-1295 amplifies that pulse at the pituitary level. Together they address GH restoration from the regulatory (Epithalon, hypothalamic signaling) and stimulatory (CJC-1295, direct pituitary activation) angles simultaneously — particularly powerful for adults over 50 where both pineal function and pituitary responsiveness have declined.
- +CJC-1295 + GHK-Cu — CJC-1295 drives GH and IGF-1 elevation that stimulates collagen synthesis; GHK-Cu amplifies collagen deposition, gene regulation, and the structural tissue remodeling that follows. A powerful anti-aging combination for skin, connective tissue, and body composition — covering both the hormonal signaling (CJC-1295/IGF-1) and the cellular execution (GHK-Cu/gene regulation) of collagen restoration.
- +CJC-1295 + BPC-157 — The tissue repair amplification stack. BPC-157 activates angiogenesis and growth factor signaling at injury sites; CJC-1295-driven IGF-1 elevation provides the systemic anabolic environment that amplifies BPC-157's local repair effects. For athletes and active adults combining recovery from injury with body composition goals, this pairing addresses both the local (BPC-157) and systemic (CJC-1295/IGF-1) dimensions of tissue repair.
Frequently Asked Questions
Both are GHRH analogs with similar mechanisms — the primary differences are half-life and clinical history. Sermorelin has FDA history (pediatric approval) and a longer real-world safety track record. CJC-1295 without DAC produces a larger GH pulse amplitude due to its longer half-life. For first-time GH secretagogue users who prioritize a conservative, well-documented option, Sermorelin is often recommended. For those seeking maximum GH pulse amplitude and comfortable with a newer compound, CJC-1295 without DAC is the choice. Both are commonly stacked with Ipamorelin.
Sleep improvement is typically the earliest benefit — often noticeable within 2–4 weeks. Energy and recovery improvements follow at 4–8 weeks. Body composition changes — fat reduction and lean mass improvement — become measurable at 3–6 months. GH optimization is a long-game intervention; expect a minimum 6-month commitment for meaningful body composition results.
IGF-1 is the primary marker — it reflects overall GH status and gives you a baseline to track against. A comprehensive metabolic panel, fasting glucose, and fasting insulin are also recommended. Retest IGF-1 at 3 months and 6 months to assess response. Target IGF-1 range for most adults is 200–300 ng/mL — your provider will set specific targets based on your age and clinical picture. Avoid pushing IGF-1 above the upper limit of the age-appropriate reference range.
CJC-1295 without DAC preserves the natural feedback loop — when GH and IGF-1 reach appropriate levels, somatostatin is released to inhibit further GH secretion. This self-regulating mechanism prevents suppression of natural GH production. Standard cycling protocols (5 nights on / 2 off, with periodic longer breaks) are used as additional precaution. CJC-1295 with DAC, with its sustained GH elevation, has a less favorable profile on this question.
Look for: Certificate of Analysis confirming ≥98% purity by HPLC, correct molecular weight confirmation, clearly labeled variant (with or without DAC — do not accept unlabeled), lyophilized powder for injectable, cold-chain shipping. Confirm the supplier can distinguish between variants and provide batch-specific testing. The DAC vs no-DAC distinction is critical — a supplier who cannot clearly identify which variant they're selling is a red flag.
Free - Instant PDF download
This page is for educational purposes only and does not constitute medical advice. CJC-1295 is not FDA-approved for any indication. Always consult a qualified, licensed healthcare provider before beginning any peptide protocol. Regular IGF-1 monitoring under physician supervision is standard practice for GH secretagogue protocols. InformedPeptides.com and its authors are not liable for actions taken based on the content of this page.